Free / total prostate specific antigen ratio for prostate cancer detection: a prospective blind study

Anticancer Res. 2005 May-Jun;25(3c):2439-43.

Abstract

Background: We conducted this prospective study to evaluate the ability of the percentage of free PSA (% fit PSA) to improve the specificity of prostate cancer (PC) detection.

Materials and methods: Seven hundred and eighty-five patients with serum PSA levels between 4 and 25 ng/ml underwent sextant biopsies of the prostate. The % f/t PSA was analyzed for the sensitivity, specificity and positive predictive values.

Results: The mean % f/t PSA of the 169 patients with PC was 18.0 +/- 7.7 and was significantly (p < 0.0001) lower than that of the 616 patients who had histologically benign biopsy specimens, with a mean % f/t PSA of 26.6 +/- 9.7. Using 30% f/t PSA as the cut-off eliminated 34.4 % of the negative biopsies while still detecting 93.4% of the carcinomas.

Conclusion: The optimal cut-off value of 30% f/t PSA may be applied as reference using the Cis bio international assay for PC detection.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prospective Studies
  • Prostate-Specific Antigen / blood*
  • Prostatic Diseases / blood
  • Prostatic Diseases / diagnosis
  • Prostatic Diseases / diagnostic imaging
  • Prostatic Diseases / pathology
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / pathology
  • ROC Curve
  • Sensitivity and Specificity
  • Single-Blind Method
  • Ultrasonography

Substances

  • Prostate-Specific Antigen